Clinical Trials Directory

Trials / Terminated

TerminatedNCT02532426

Influence of Chronic Hypoxia on Oxidative Phenotype in Patients With Chronic Obstructive Pulmonary Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In addition to chronic airflow obstruction, patients with Chronic Obstructive Pulmonary Disease (COPD) suffer from skeletal muscle dysfunction which is a prominent and disabling feature and also an independent determinant of survival. Muscular impairment involves loss of muscle oxidative phenotype (OXPHEN: a slow-to-fast shift in fibre types and reduced oxidative capacity). Since hypoxia obviously is a key feature of COPD, the aim of this study is to elucidate the role of hypoxia in loss of muscle OXPHEN. Thus, OXPHEN and expression levels of its key regulators will be determined in the baseline biopsies for association with the degree of hypoxemia. In addition, expression levels of the key OXPHEN regulators will be measured in pre/post exercise biopsies.

Conditions

Interventions

TypeNameDescription
PROCEDUREMuscle biopsyThe biopsy is performed on the vastus lateralis muscle at rest and 2 hours after an acute exercise, with a local anesthesia.

Timeline

Start date
2012-05-18
Primary completion
2017-09-30
Completion
2017-09-30
First posted
2015-08-25
Last updated
2017-10-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02532426. Inclusion in this directory is not an endorsement.

Influence of Chronic Hypoxia on Oxidative Phenotype in Patients With Chronic Obstructive Pulmonary Disease (NCT02532426) · Clinical Trials Directory